Literature DB >> 33363932

Can COVID-19 cause severe neutropenia?

Patricia López-Pereira1, Isabel Iturrate1, Rafael de La Cámara1, Laura Cardeñoso2, Adrián Alegre1, Beatriz Aguado1.   

Abstract

This is the first case of acquired severe neutropenia in the context of COVID-19 reported to date. This could illustrate another less frequent hematological disorder related to this novel viral infection.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID‐19; G‐CSF; coronavirus; neutropenia

Year:  2020        PMID： 33363932      PMCID： PMC7752313          DOI： 10.1002/ccr3.3369

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN： 2050-0904


  5 in total

1.  Dilemma of Tocilizumab therapy for a patient with critical COVID-19 disease and neutropenia: Case report and review of the literature.

Authors:  Ahmad Al Bishawi; Shiema Abdalla; Marwa Askar; Wael Kanjo; Amal Sameer; Gihan Mustafa; Hamad Abdel Hadi; Muna Al Maslamani; Alaaeldin Abdelmajid
Journal:  Clin Case Rep       Date:  2022-05-27

2.  Delayed, transient and self-resolving neutropenia following COVID-19 pneumonia.

Authors:  Victoria Marie Ferreira Mank; Jeffrey Mank; Jenie Ogle; Jefferson Roberts
Journal:  BMJ Case Rep       Date:  2021-05-12

3.  Self-limiting severe neutropenia in a patient with COVID-19.

Authors:  Ram Singh; Brajesh Kumar Ratre; Prashant Sirohiya; Sushma Bhatnagar
Journal:  BMJ Case Rep       Date:  2021-11-30

4.  Transient severe neutropenia in an infant with SARS-CoV-2 infection.

Authors:  Shinji Irie; Shirou Matsumoto
Journal:  Pediatr Neonatol       Date:  2022-02-26       Impact factor: 2.586

5.  Ethnicity-Specific Features of COVID-19 Among Arabs, Africans, South Asians, East Asians, and Caucasians in the United Arab Emirates.

Authors:  Fatmah Al Zahmi; Tetiana Habuza; Rasha Awawdeh; Hossam Elshekhali; Martin Lee; Nassim Salamin; Ruhina Sajid; Dhanya Kiran; Sanjay Nihalani; Darya Smetanina; Tatsiana Talako; Klaus Neidl-Van Gorkom; Nazar Zaki; Tom Loney; Yauhen Statsenko
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.